Gilead expects to fill 80 of the positions over the coming 12 months, with the remainder hired by early 2022.
Gilead is adding positions at all levels in departments including clinical development, process development and analytical operations, legal, human resources, supply chain, information technology, facilities and engineering, and financial shared services.
As part of the expansion, the company will also establish a paediatric centre of excellence in Ireland.
The company is currently selecting a location for its new Dublin office, where the majority of the new positions will be based, with the remaining roles located at Gilead’s existing Cork facilities.
Gilead has been operating in Ireland since 1999, when it acquired NeXstar.
Initially it focused on testing, release and distribution for the EU market but now operations have expanded to include drug product manufacturing and packaging.
Currently, the company has 370 full-time employees in Ireland and an additional 119 contingent workers.
Gilead’s sites in Ireland include a drug product manufacturing and packing facility in Carrigtwohill, Co Cork for 22 drug products.
The facility manufactures HIV and HCV solid oral products, representing 25% of Gilead’s total solid oral drug production.
The company also has a financial shared services centre in Little Island, Co Cork, which supports Gilead affiliates in Europe, Middle East, Asia and South America. This was established 11 years ago.
Finally, a distribution centre in Dublin distributes to 90 markets worldwide.
Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California. Initially in Ireland, the US pharmaceutical company focused on testing, release and distribution for the EU market.